Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study - PubMed (original) (raw)

Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study

G M Franklin et al. Diabetes Care. 1994 Oct.

Abstract

Objective: To investigate risk factors for distal symmetric (sensory) neuropathy among prevalent cases of non-insulin-dependent diabetes mellitus (NIDDM) in a population-based study in southern Colorado.

Research design and methods: Prevalent neuropathy was identified in 77 of 277 people with NIDDM by a standardized history and neurologic examination. Fifteen known or suspected risk factors for neuropathy were determined without knowledge of neuropathy status.

Results: Older age at examination, longer duration of diabetes, higher glycohemoglobin percentage, lower fasting C-peptide, insulin use, and presence of retinopathy and nephropathy (microalbumin > or = 200 micrograms/ml) were all significantly associated with neuropathy. Sex, ethnicity (Hispanic versus non-Hispanic white), height, systolic blood pressure, peripheral vascular disease, cigarette and alcohol use, and serum lipid levels were not significantly associated with neuropathy. In a multivariate logistic model, increasing age (odds ratio [OR] = 1.3, 95% confidence interval [CI] = 1.1-1.6), longer duration of diabetes (OR = 1.3, CI = 1.0-1.6), increased glycohemoglobin percentage (OR = 1.5, CI = 1.1-2.1), and insulin use (OR = 2.8, CI = 1.3-6.1) were associated with neuropathy. Retinopathy (OR = 3.0, CI = 1.2-7.7), but not nephropathy, was important when added to this model.

Conclusions: Worse glycemic control and insulin use were independently associated with neuropathy in people with NIDDM. Whether insulin use represents another marker for severity of the metabolic disturbance or is an independent risk factor for neuropathy requires further study. We could not confirm associations of neuropathy with height, with nephropathy, or with retinopathy, independent of duration of diabetes.

PubMed Disclaimer

Cited by

Autonomic neuropathy in dialysis patients - investigations with a new symptom score (COMPASS 31).
Schramm CV, Schramm MC, Trautner M, Hinz M, Mitzner S. Schramm CV, et al. BMC Nephrol. 2024 Aug 8;25(1):256. doi: 10.1186/s12882-024-03691-y. BMC Nephrol. 2024. PMID: 39118055 Free PMC article.
Prevalence of peripheral artery disease in patients with infectious diabetic foot ulcer in Imam Reza Hospital in Kermanshah during 2019-2020.
Janbakhsh A, Abedinfam M, Sobhiyeh MR, Rezaie M, Aslani PS, Vaziri S, Sayad B, Afsharian M, Mansouri F. Janbakhsh A, et al. J Educ Health Promot. 2021 May 31;10(1):170. doi: 10.4103/jehp.jehp_907_20. eCollection 2021. J Educ Health Promot. 2021. PMID: 34250104 Free PMC article.
Feasibility and Effectiveness of Electrochemical Dermal Conductance Measurement for the Screening of Diabetic Neuropathy in Primary Care. Decoding Study (Dermal Electrochemical Conductance in Diabetic Neuropathy).
Cabré JJ, Mur T, Costa B, Barrio F, López-Moya C, Sagarra R, García-Barco M, Vizcaíno J, Bonaventura I, Ortiz N, Flores-Mateo G, Solà-Morales O; Catalan Diabetes Prevention Research Group. Cabré JJ, et al. J Clin Med. 2019 May 1;8(5):598. doi: 10.3390/jcm8050598. J Clin Med. 2019. PMID: 31052426 Free PMC article.
Polyneuropathy in Severely Obese Women Without Diabetes: Prevalence and Associated Factors.
Dias LS, Nienov OH, Machado FD, Ramos CP, Rodrigues D, Menguer RK, Schmid H. Dias LS, et al. Obes Surg. 2019 Mar;29(3):953-957. doi: 10.1007/s11695-018-03627-0. Obes Surg. 2019. PMID: 30536202

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study - PubMed (original) (raw)